Medical Condition News

RSS

UCSF-led research team targets physiological factors that lead to asthma attack

A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding the two most significant biological responses that lead to an asthma attack.

18 Sep 2012

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Sentara Heart Hospital is leading the way in an innovative Atrial Fibrillation (AF) procedure for what is typically the most difficult to treat or persistent, forms of AF. This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study (Staged DEEP) feasibility trial.

18 Sep 2012

Scripps Florida scientist receives two grants to focus on sulfenylation

A scientist from the Florida campus of The Scripps Research Institute has been awarded a pair of grants totaling $2.8 million from the National Institute of General Medical Sciences of the National Institutes of Health, and from TargAnox, a Massachusetts-based biotechnology firm.

18 Sep 2012

Brain-healthy lifestyle may prevent symptoms of Alzheimer's

Alzheimer's disease is the sixth leading cause of death in the U.S., and that figure isn't going down. In fact, as America's older population grows, deaths from Alzheimer's continue to rise, and have increased 66 percent since 2000. If current population trends continue and no cure is found, the actual number of people living with the disease could double every 20 years.

18 Sep 2012

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.

17 Sep 2012

Additional campus-based health promotion strategies needed for students

A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.

17 Sep 2012

Nanoparticles for non-invasive photodynamic therapy of deep cancer

National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.

17 Sep 2012

Wockhardt receives FDA marketing approval for Lansoprazole

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.

17 Sep 2012

Orthopedists should suspect necrotizing fasciitis in patients with out of proportion pain

Dr. Russell Russo, an Orthopedic Surgeon at LSU Health Sciences Center New Orleans, and other researchers stress that orthopedists should have a high index of suspicion for necrotizing fasciitis, or flesh-eating bacterial infection, in every patient with pain or other symptoms that are out of proportion to the initial diagnosis. Their recommendations are published in the September 2012 issue of Orthopedics Today.

17 Sep 2012

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.

17 Sep 2012

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod.

17 Sep 2012

Researchers identify gene mutations in Wolfram syndrome that affects insulin-secreting beta cells

The rare disorder Wolfram syndrome is caused by mutations in a single gene, but its effects on the body are far reaching. The disease leads to diabetes, hearing and vision loss, nerve cell damage that causes motor difficulties, and early death.

17 Sep 2012

vasopharm's explorative phase IIa NOSTRA trial in TBI meets clinical endpoints for safety

vasopharm GmbH, a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases, today announces that the explorative phase IIa NOSTRA trial in Traumatic Brain Injury Patients met all clinical endpoints for safety and in addition demonstrated strong evidence of clinical benefit in patients.

17 Sep 2012

NIH announces multiple awards to UCLA Center for Autism Research and Treatment

The National Institutes of Health, recognizing UCLA's preeminence in both research and clinical care of children with autism, has announced multiple awards to the university as part of its Autism Centers of Excellence (ACE) research program.

17 Sep 2012

Children without siblings at higher risk of being overweight or obese

Children who grow up without siblings have a more than 50 percent higher risk of being overweight or obese than children with siblings. This is the finding of a study of 12,700 children in eight European countries, including Sweden, published in Nutrition and Diabetes. The University of Gothenburg, Sweden, was one of the participating universities in the study.

17 Sep 2012

Limited positive effect of Tafamidis in neurological disorders

Tafamidis meglumine was approved in November 2011 for the treatment of transthyretin amyloidosis in adults.

17 Sep 2012

VTT, GE Healthcare enter collaboration for AD research

Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.

17 Sep 2012

Positive results from Targacept TC-5619 Phase 2 trial for inattentive-predominant attention deficit/hyperactivity disorder

Targacept, Inc. today announced top-line results from a Phase 2 trial of TC-5619 as a treatment for inattentive-predominant attention deficit/hyperactivity disorder (ADHDi). In the trial, TC-5619 did not meet the primary outcome measure, change from baseline on the inattention subscale of the Conners' Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo.

17 Sep 2012

Natural antibiotic to treat tuberculosis

A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.

17 Sep 2012

Researchers investigate African plants effective in treating snakebite

A PhD student at the University of Copenhagen has drawn on nature's own pharmacy to help improve the treatment of snakebites in Africa.

17 Sep 2012

Medical Condition News

UCSF-led research team targets physiological factors that lead to asthma attack

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Scripps Florida scientist receives two grants to focus on sulfenylation

Brain-healthy lifestyle may prevent symptoms of Alzheimer's

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

Additional campus-based health promotion strategies needed for students

Nanoparticles for non-invasive photodynamic therapy of deep cancer

Wockhardt receives FDA marketing approval for Lansoprazole

Orthopedists should suspect necrotizing fasciitis in patients with out of proportion pain

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

Researchers identify gene mutations in Wolfram syndrome that affects insulin-secreting beta cells

vasopharm's explorative phase IIa NOSTRA trial in TBI meets clinical endpoints for safety

NIH announces multiple awards to UCLA Center for Autism Research and Treatment

Children without siblings at higher risk of being overweight or obese

Limited positive effect of Tafamidis in neurological disorders

VTT, GE Healthcare enter collaboration for AD research

Positive results from Targacept TC-5619 Phase 2 trial for inattentive-predominant attention deficit/hyperactivity disorder

Natural antibiotic to treat tuberculosis

Researchers investigate African plants effective in treating snakebite

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News